# BlackRock Income and Growth Investment Trust plc Portfolio Update

- Link: https://www.directorstalkinterviews.com/blackrock-income-growth-portfolio-update/412810756
- Published: 2020-03-20T13:37:20+00:00
- Author: Amilia Stone

**All information is at 29 February 2020 and unaudited.**

Performance at month end with net income reinvested

|  | **One**
**Month** | **Three****Months** | **One****Year** | **Three****Years** | **Five****Years** | **Since****1 April** **2012** | 
| **Sterling** |  |  |  |  |  |  | 
| Share price   |  -11.0% |   -8.7% |   -2.3% | 0.0% | 13.2% | 76.5% | 
| Net asset value |   -9.7% |   -8.7% |   -0.6% | 2.9% | 16.4% | 69.4% | 
| FTSE All-Share Total Return |   -8.9% |   -8.9% |   -1.4% | 4.7% | 19.1% | 64.0% |

 Source: BlackRock

BlackRock took over the investment management of the Company with effect from 1 
April 2012.

| **At month end** |  | 
| Sterling: |  | 
| Net asset value – capital only: | 183.37p | 
| Net asset value – cum income*: | 185.34p | 
| Share price: | 176.00p | 
| Total assets (including income): | £46.3m | 
| Discount to cum-income NAV: | 5.0% | 
| Gearing: | 4.4% | 
| Net yield**: | 4.1% | 
| Ordinary shares in issue***: | 22,840,600 | 
| Gearing range (as a % of net assets) | 0-20% | 
| Ongoing charges****: | 1.1% |

* includes net revenue of 1.97 pence per share
 ** The Company’s yield based on 
dividends announced in the last 12 months as at the date of the release of this 
announcement is 4.1% and includes the 2019 final dividend of 4.60p per share declared
on 24 December 2019 and due to be paid to shareholders on 19 March 2020, and the
2019 interim dividend of 2.60p per share declared on 25 June 2019 and paid to shareholders
on 2 September 2019. *** excludes 10,093,332 shares held in treasury **** Calculated
as a percentage of average net assets and using expenses, excluding performance 
fees and interest costs for the year ended 31 October 2019.

| **Sector Analysis** | **Total assets (%)** | 
| Financial Services | 8.7 | 
| Media | 7.9 | 
| Pharmaceuticals & Biotechnology | 7.7 | 
| Food Producers | 7.7 | 
| Oil & Gas Producers | 7.6 | 
| Support Services | 7.2 | 
| Banks | 6.8 | 
| Household Goods & Home Construction | 6.0 | 
| Gas, Water & Multiutilities | 4.4 | 
| Tobacco | 4.4 | 
| Life Insurance | 4.4 | 
| Mining | 4.4 | 
| Travel & Leisure | 4.3 | 
| Food & Drug Retailers | 3.8 | 
| Health Care Equipment & Services | 2.9 | 
| Mobile Telecommunications | 2.7 | 
| Electronic & Electrical Equipment | 1.2 | 
| Nonlife Insurance | 1.1 | 
| Industrial Engineering | 0.8 | 
| General Retailers | 0.6 | 
| Construction & Materials | 0.6 | 
| Beverages | 0.2 | 
| Net Current Assets | 4.6 | 
|  | —— | 
| Total | 100.0 | 
|  | ====== | 
|  |  | 
| **Ten Largest Equity Investments** |  | 
| **Company** | **Total assets (%)** | 
| AstraZeneca | 5.7 | 
| Royal Dutch Shell ‘B’ | 4.7 | 
| RELX | 4.6 | 
| National Grid | 4.4 | 
| Unilever | 4.4 | 
| British American Tobacco | 4.4 | 
| BHP | 4.4 | 
| Tesco | 3.8 | 
| Associated British Foods | 3.3 | 
| BP Group | 2.9 |

**Commenting on the markets, Adam Avigdori and David Goldman representing the Investment
Manager noted:**

The coronavirus outbreak replaced trade deals as the main focus for the markets 
in February. Near-term negative effects on the Chinese economy and its impact on
global growth, together with the expectation that central banks around the world
will provide further monetary support, sent government bond yields lower throughout
the month, with the US 10Y bond yield hitting a new all-time low of 1.1%. The Chinese
manufacturing purchasing managers’ index (PMI), one of the first official economic
indicators published since the coronavirus outbreak, fell to 35.7 in February, an
all-time low and down from 50 in January. For the initial weeks of February, markets
looked through concerns about the outbreak, supported by a better-than-expected 
Q4 US earnings season, improving business surveys in January and the expectation
that the virus’ impact would be short-lived and contained. However, markets sold
off sharply by the end of the month as the virus has spread across the globe. Emerging
markets outperformed developed markets, and the S&P 500 saw its fastest 10% fall
in a week ever.

China has stepped up its economic loosening with several supportive measures being
announced, such as cutting the loan prime rate by 10bp, but it remains to be seen
how quickly and sharply activity will recover. Whilst the Eurozone composite PMI
rose to 51.6 in February, consistent with trend GDP growth, flash PMI details for
February showed significant impact from the coronavirus virus. The economy is vulnerable
to global supply chain disruptions though downside risks to growth need to be balanced
with expectations for fiscal measures that are likely to be announced. Risk aversion
has not been isolated to equities. Fears over the virus, global demand as well as
stalling negotiations between Russia and OPEC on the implementation of further supply
cuts saw the oil price fall another 13%, down 27% year-to-date.

In the UK, fiscal policy reached a critical inflection point with two developments:
the approval of the roughly £100 billion HS2 and the resignation of Chancellor of
the Exchequer, Sajid Javid. Rishi Sunak the new Chancellor delivered a budget that
surpassed the Labour party’s after the financial crisis. Needless to say, this has
been overshadowed since by news relating to the spread of the coronavirus. The FTSE
All Share index fell -8.89% in February with Oil & Gas, Basic Materials, and Telecommunications
as top underperformers.

Over the month, the Company returned -9.7%, underperforming the benchmark, the FTSE
All-Share which returned -8.9%.

Premier Miton Group was the largest detractor to the Company. The stock saw price
weakness, reacting to the weakness seen in the stock market, although we remain 
constructive on its recent merger supported by a strong balance sheet. AB Foods 
also detracted from performance on supply chain fears and virus contagion affecting
footfall. This overwhelmed supportive full year results. Again, this remains a high
quality, long term compounder in our view with market leading positions or products
across its portfolio. Importantly, it also has net cash on its balance sheet, remains
conservatively financed and can independently fund its own growth.

National Grid contributed to performance. Utilities stocks generally performed well
in the market sell-off. Rentokil also contributed to performance after the company
announced solid full-year results which demonstrated strong growth and cash generation
with limited coronavirus impact.

We sold positions in Weir Group and Centrica. We reduced holdings in [GlaxoSmithKline](https://www.directorstalkinterviews.com/ftse-company/glaxosmithkline-plc/gsk.l)
and HSBC. We added to positions in BHP Group, Unilever and AstraZeneca.

2019 proved to be a strong year for equity investors, with the FTSE All-Share returning
19%. The 2020 macro environment marks a big shift from the dynamics of 2019, when
an unusual late-cycle dovish pivot by central banks helped offset the negative effect
of rising trade tensions.

From a valuation perspective, we recognise that for the most part, valuations are
high but not excessive, with trailing p/e of 19x, up from 15x a year ago. On a free
cash flow basis, equity markets still look attractive, with the UK the stand-out
at 6.3% and around a 30% discount to the MSCI World across a range of valuations.

For the UK economy, and the equity market, the picture looks better than it has 
done for a number of years. For the domestic-facing economy, the Conservative majority
has brought more political certainty and indeed, although it is early days, we have
seen signs of sentiment and investment returning following the election result. 
We expect this to continue.

We believe the UK’s economic climate has the potential to improve over the medium-
term, supported by an expected increase in public sector spending. With the backdrop
of ‘full’ employment, the recently announced increase to the national living wage
suggests disposable income will continue to improve with underlying growth in nominal
and real wages for the first time in recent years.

We are also conscious that Environmental, Social and Governance matters (“ESG”) 
are increasingly at the forefront of shareholders’ minds. We have always looked 
to our companies to operate within a healthy ecosystem of all their stakeholders
whether these are shareholders, employees, customers, regulators or suppliers. It
is our belief that a company’s ‘ecosystem’ is crucial to ensuring the [sustainability](https://www.directorstalkinterviews.com/sustainability-green-stocks-news)
of long-term returns.

For those who have been following our strategy, we continue to employ a bottom-up
approach rather than focusing on a specific macro outcome. We believe in identifying
franchises across the UK market which can sustain their competitive advantages over
the long term, supporting strong and consistent cash generation. Hence, we will 
continue to focus the portfolio on stock specific risk where our resources and long-
term analysis is best able to deliver capital and income growth over the long-term
for shareholders.

It is certain that coronavirus will have some impact on the global economy, but 
as the extent of the virus is as yet unknown, it is impossible to quantify its severity
and duration. We believe our focus on the stock specifics with a bias towards strong
balance sheets will provide support for the portfolio in difficult times. We reduced
the gearing in the portfolio significantly during January and the early part of 
February. Hence, we believe we enter this period well positioned and, as always,
we will look to take advantage in shares we like where prices have fallen to levels
we find attractive, so that the Company emerges from this period in a stronger position.

Share on:
